pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,697 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 201 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: patent expiry×type: phase readout×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa201
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area
    • Infectious Disease9
    • Oncology2
    • Dermatology1
    • Pulmonology1

    Date TBD

    50
    ›RECRUITINGphase readoutNCT05005403: Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

    Sponsor: AbbVie. Phase: PHASE1. Conditions: Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Micro Satellite Stable Colorectal Cancer, Gastric/Esophageal Cancer, High-Grade Serous Ovarian Cancer, Pancreatic Cancer, Triple Negative Breast Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03872427: Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor, Unresectable Malignant Solid Neoplasm

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07367061: Clinical Investigation to Assess Safety and Efficacy of INNEA AQUA in Adult Women With Vulvo-Vaginal Atrophy (VVA)

    Sponsor: Innate srl. Phase: NA. Conditions: Vulvo Vaginal Atrophy

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05042661: Acupuncture-like Transcutaneous Electrical Nerve Stimulation on Bowel Symptom and Quality of Life in Patients With Irritable Bowel Syndrome

    Sponsor: National Taipei University of Nursing and Health Sciences. Phase: NA. Conditions: Acupuncture-like Transcutaneous Electrical Nerve Stimulation, Irritable Bowel Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05665361: Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)

    Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07559786: A Multicenter, Randomized, Cohort, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy

    Sponsor: Henan Cancer Hospital. Phase: PHASE2. Conditions: SCLC, Limited Stage

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03849586: Registry for Patients Undergoing Penile Prosthesis Implantation for Male Erectile Dysfunction

    Sponsor: European Association of Urology Research Foundation. Phase: . Conditions: Erectile Dysfunction

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05691270: Contraception Navigator Program

    Sponsor: Indiana University. Phase: NA. Conditions: Contraception, Contraceptive Usage, Health Care Utilization

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07058883: Evaluation of Juläine (TM) for the Treatment of Atrophic Facial Acne Scars

    Sponsor: Nordberg Medical AB. Phase: NA. Conditions: Acne Scars

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05336383: Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Multiple Myeloma, Plasma Cell Neoplasm, Malignant Plasma Cell Neoplasm

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07258641: Fluorescence Imaging of Adalimumab-680LT and Risankizumab-800CW in Inflammatory Bowel Disease

    Sponsor: University Medical Center Groningen. Phase: PHASE1. Conditions: Ulcerative Colitis (UC), Crohn Disease (CD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05731141: A Prospective Natural History Study of Lymphatic Anomalies

    Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Lymphatic Diseases, Lymphatic Abnormalities

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07454954: The Effect of Blood Flow Restriction Training Combined With Transcranial Magnetic Stimulation on Limb Function in Hemiplegic Patients After Stroke

    Sponsor: The First Affiliated Hospital of Zhengzhou University. Phase: NA. Conditions: Stroke, Hemiplegia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07066254: The Mepilex Cesarean Delivery Trial

    Sponsor: Montefiore Medical Center. Phase: NA. Conditions: Surgical Site Infection Following Cesarean Delivery

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07348354: Standardization and Application of Pure Platelet-Rich Plasma in Improving Sperm Function

    Sponsor: Chinese University of Hong Kong. Phase: NA. Conditions: Infertility

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05462405: Evaluation of Sympathetic Activity Effects by the BackBeat Medical Cardiac Neuromodulation Therapy (CNT).

    Sponsor: BackBeat Medical Inc. Phase: NA. Conditions: Hypertension

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05790694: A Trial of HBM9378 in Healthy Chinese Subjects

    Sponsor: Harbour BioMed (Guangzhou) Co. Ltd.. Phase: PHASE1. Conditions: Asthma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05554094: Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder

    Sponsor: Ohio State University. Phase: PHASE2. Conditions: PTSD, Stress Disorders, Traumatic, Stress Disorders, Post-Traumatic, Trauma and Stressor Related Disorders, Mental Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03386266: Biomarkers and Validation of Selected Outcome Measures (CMTBiomarker)

    Sponsor: University Medical Center Goettingen. Phase: . Conditions: Charcot-Marie-Tooth Disease, Type IA

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06623422: A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: Carcinoma, Non-Small-Cell Lung

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06705751: Speed-up the Diagnosis and Evaluation of anoMalous Coronary ARTery From the Aorta

    Sponsor: IRCCS Policlinico S. Donato. Phase: NA. Conditions: AAOCA, ACAOS, Anomalous Aortic Origin of the Coronary Artery (AAOCA), Anomalous Coronary Artery Arising From the Opposite Sinus, Anomalous Coronary Artery Origin, Anomalous Coronary Artery With Aortic Origin and Course Between the Great Arteries, Coronary Anomaly, Sudden Cardiac Death, Myocardial Ischemia, Myocardial Ischemia, Angina Pectoris

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02296229: Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer

    Sponsor: Jonsson Comprehensive Cancer Center. Phase: NA. Conditions: Adenocarcinoma of the Prostate, Stage III Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07525453: Effects of Three Different Exercise Programs on Dynamic Balance in Community-Dwelling Older Adults

    Sponsor: Fenerbahce University. Phase: NA. Conditions: Balance Disorders, Aging, Risk of Falling in the Elderly

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07196137: Comparing the Effect of LTS and Air-Q sp3G LMA Use on Gastric Insufflation Using Ultrasound

    Sponsor: Ankara City Hospital Bilkent. Phase: . Conditions: Laryngeal Masks Comparison, Elective Surgeries, Gastric Ultrasonography, Gastric Insufflation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05343637: A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension

    Sponsor: Respira Therapeutics, Inc.. Phase: PHASE2. Conditions: Pulmonary Arterial Hypertension

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07338045: The Effects of Eight-Week Baduanjin Exercise on Chronic Low Back Pain and Disability Among Office Workers.

    Sponsor: Universiti Sains Malaysia. Phase: NA. Conditions: Low Back Pain, Baduanjin

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04553939: Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer

    Sponsor: Henan Cancer Hospital. Phase: PHASE2. Conditions: Urothelial Carcinoma, Bladder Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03911739: Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study

    Sponsor: T. John Winhusen, PhD. Phase: . Conditions: Opioid-Related Disorders, Drug Addiction, Pregnancy Related, Substance Abuse, Drug Abuse, Neonatal Abstinence Syndrome, Neonatal Opiate Withdrawal Syndrome, Drug Abuse in Pregnancy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07353177: Effects of HIPEC on Postoperative Bowel Motility and Complications

    Sponsor: Peking University People's Hospital. Phase: . Conditions: HIPEC, Gastro Intestinal Cancer, Adhesion Prevention, Bowel Functions

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07190495: Ginger to Prevent Nausea and Vomiting After Laparoscopic Cholecystectomy

    Sponsor: University Tunis El Manar. Phase: PHASE4. Conditions: Postoperative Nausea and Vomiting, Laparoscopic Cholecystectomy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07351539: The Effects of Plyometric Training on Balance, Joint Position Sense, and Explosive Strength

    Sponsor: Selcuk University. Phase: NA. Conditions: Effects of Plyometric Training on Balance, Joint Position Sense, and Explosive Strength in Healthy Young Taekwondo Athletes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06486077: Metabolic Health 1: Power Line Evaluation; Effect Size Determination

    Sponsor: Nature's Sunshine Products, Inc.. Phase: NA. Conditions: Metabolic Health

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03707977: Dual bNAb Treatment in Children

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: HIV Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07283757: PTSD Treatment for Incarcerated Men and Women: AV

    Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: PTSD

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07470281: Oral Mucosa Wound Healing After Gingival Recession Treatment in Diabetic Patients. A Clinical Study.

    Sponsor: Mauro Santamaria. Phase: NA. Conditions: Diabetes Mellitus, Gingival Recession, Generalized, Gingival Recession, Localized

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06837220: Implementation of Tobacco Cessation Programming at Community Behavioral Health Sites

    Sponsor: University of Chicago. Phase: NA. Conditions: Nicotine Use Disorder, Smoking Cessation, Smoking Cessation Intervention

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07566260: Stress and Menstrual Health

    Sponsor: Duke University. Phase: NA. Conditions: Menstrual Dysfunction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07329023: An Implementation Science Approach to Evaluating Self-Administered Acupressure for Knee Osteoarthritis in Older-Aged Adults in the Community

    Sponsor: The Hong Kong Polytechnic University. Phase: NA. Conditions: Knee Osteoarthritis (Knee OA)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04960059: NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts

    Sponsor: The Christie NHS Foundation Trust. Phase: . Conditions: Cancer, Metastatic Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05503862: Home Semen Testing in Men Beginning Attempts to Conceive

    Sponsor: Northwestern University. Phase: NA. Conditions: Male Infertility

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05689762: Promotion of Healthy Lifestyle Habits in Primary Care Settings

    Sponsor: Örebro University, Sweden. Phase: NA. Conditions: Healthy Lifestyle

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03652246: Evaluation of the Diagnostic Contribution of High-throughput Exome Sequencing for Patients With Convulsive Encephalopathy of Unknown Etiology: Pilot Study to Improve Genetic Counselling

    Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Epileptic Encephalopathy of Unindentified Genetic Origin

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07473388: Clipless Versus Conventional Laparoscopic Cholecystectomy Using Harmonic Scalpel

    Sponsor: Services Hospital, Lahore. Phase: NA. Conditions: Cholecystectomy, Laparoscopic, Cholecystitis, Gall Stones (& [Calculus - Gall Bladder])

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07481903: Effect of Acupuncture on Psychoneurological Symptom Cluster in Breast Cancer Survivors

    Sponsor: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Phase: NA. Conditions: Psychoneurological Symptom Cluster(Pain, Insomnia, Anxiety, Fatigue, Depression, Subjective Cognitive Decline), Pain, Insomnia, Anxiety, Fatigue, Depression, Subjective Cognitive Decline (SCD)

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07011303: Investigation of the Effect of Horizontal Platelet Rich Fibrin Placed in Tooth Extraction Sockets on Bone Formation

    Sponsor: Tokat Gaziosmanpasa University. Phase: NA. Conditions: Tooth Loss, Dental Implant Failed, Alveolar Bone Loss

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07582627: Acceptance and Commitment Therapy for Parents of Children With ASD: Effects on Cognitive Fusion, Stigma, and Mindfulness

    Sponsor: University of Jazan. Phase: NA. Conditions: Autism Spectrum Disorder (ASD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07391527: Early Detection of Developmental Abnormalities of Preterm Infants at 5 Years of Age

    Sponsor: Institute of Health Information and Statistics of the Czech Republic. Phase: NA. Conditions: 5 Year Old Children Born Prematurely

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07364461: Diagnostic Accuracy of IgA Anti-transglutaminase Antibodies Measured by CLIA for Predicting Villous Atrophy in Coeliac Disease

    Sponsor: Hospital Mutua de Terrassa. Phase: . Conditions: Coeliac Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07316842: SVR12 in Genotype 3 HCV (F0-F2) Treated With RDV + SOF

    Sponsor: Center of target therapy. Phase: . Conditions: Viral Hepatitis C

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06059586: Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy

    Sponsor: Indiana University. Phase: NA. Conditions: Dyspareunia, Pelvic Pain, Sexual Dysfunction, Radiation Toxicity

    full page →ctgov ↗
    ← prev
    page 27 of 94
    next →